Publication date: December 2026 Source: Ophthalmology Science, Volume 6, Issue 12 Author(s): Jonathan Eintracht, Nicholas Owen, Maria Toms, Brian Ho Ching Chan, Joe Rainger, Mariya Moosajee
A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma. // Ophthalmology Science. – URL: https://www.sciencedirect.com/science/article/pii/S2666914526003611?dgcid=rss_sd_all
A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma. Ophthalmology Science. https://www.sciencedirect.com/science/article/pii/S2666914526003611?dgcid=rss_sd_all
“A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma.” Ophthalmology Science.
@article{article60892,
title = {A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma},
journal = {Ophthalmology Science},
url = {https://www.sciencedirect.com/science/article/pii/S2666914526003611?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...